KCNQ1OT1 and nervous system disorder: For instance, KCNQ1OT1 inhibition can reduce neuronal apoptosis and neuroinflammation by controlling the miR-30e-3p/NLRP3 axis, indicating that KCNQ1OT1 and miR-30e-3p may be promising therapeutic targets for the treatment of neurological disorders [99].